JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-01 ,pp. : 1098-1109

Bentham Science Publishers

Access to resources Recommend Favorite

Advantages of the quenching probe method over other PCR-based methods for detection of the JAK2 V617F mutation

By            

Oncology Letters, Vol. 4, Iss. 2, 2012-01 ,pp. : 205-208

Spandidos Publications

Access to resources Recommend Favorite

Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 735-738

Spandidos Publications

Access to resources Recommend Favorite

A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia

By Shimanovsky Alexei  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1567-1568

Informa Healthcare

Access to resources Recommend Favorite

JAK2 V617F detected in two Bcell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosomenegative myeloproliferative neoplasms: A report of two cases

By      

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 841-844

Spandidos Publications

Access to resources Recommend Favorite